Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
Despite the abundance of data concerning biologic treatments for patients with psoriasis, clinicians are often challenged with discerning the optimal treatment for each patient. To inform this selection, this study explored whether a patient's baseline characteristics or disease profile could p...
Saved in:
Main Authors: | April W. Armstrong (Author), Elisabeth Riedl (Author), Patrick M. Brunner (Author), Stefano Piaserico (Author), Willie I. Visser (Author), Natalie Haustrup (Author), Bruce W. Konicek (Author), Zbigniew Kadziola (Author), Mercedes Nunez (Author), Alan Brnabic (Author), Christopher Schuster (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO
by: Elisabeth Riedl, et al.
Published: (2024) -
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)
by: A. Pinter, et al.
Published: (2023) -
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)
by: A. Pinter, et al.
Published: (2024) -
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
by: Andreas Pinter, et al.
Published: (2024) -
Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)
by: Travaglini M, et al.
Published: (2023)